CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$122,000
+19.6%
90,6760.0%0.00%
Q4 2018$102,000
-53.0%
90,676
+15.2%
0.00%
Q3 2018$217,000
-22.8%
78,7130.0%0.00%
-100.0%
Q2 2018$281,000
+16.1%
78,7130.0%0.00%0.0%
Q1 2018$242,000
-52.2%
78,713
-1.9%
0.00%0.0%
Q4 2017$506,000
-8.0%
80,262
-0.3%
0.00%0.0%
Q3 2017$550,000
+15.1%
80,471
+20.1%
0.00%0.0%
Q2 2017$478,000
-27.4%
67,020
-6.4%
0.00%0.0%
Q1 2017$658,000
+117.9%
71,620
-4.3%
0.00%0.0%
Q4 2016$302,000
+2.4%
74,820
-2.7%
0.00%0.0%
Q3 2016$295,000
-10.1%
76,920
+0.8%
0.00%0.0%
Q2 2016$328,000
-7.3%
76,320
-0.3%
0.00%0.0%
Q1 2016$354,000
-47.3%
76,520
+14.2%
0.00%
-50.0%
Q4 2015$672,000
+36.9%
66,987
+1.8%
0.00%
+100.0%
Q3 2015$491,000
-84.3%
65,787
-0.3%
0.00%
-87.5%
Q2 2015$3,130,000
+52.5%
65,987
+17.8%
0.01%
+60.0%
Q1 2015$2,052,000
+6.8%
56,008
+15.7%
0.01%0.0%
Q4 2014$1,922,000
+136.7%
48,408
+18.9%
0.01%
+150.0%
Q3 2014$812,000
+49.5%
40,702
+1.1%
0.00%
+100.0%
Q2 2014$543,000
+96.7%
40,271
+58.7%
0.00%0.0%
Q1 2014$276,000
-19.5%
25,3710.0%0.00%0.0%
Q4 2013$343,000
+46.6%
25,371
+23.3%
0.00%0.0%
Q3 2013$234,000
+66.0%
20,571
+2.5%
0.00%
Q2 2013$141,00020,0710.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2018
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders